Type I Diabetes TCM Therapeutic R&D
Centered on the 'Lower Wasting' theory of Xiao-Ke (Wasting-Thirst) disease, targeting kidney-yin deficiency and essence leakage, using authentic herbs for nourishing yin, supplementing kidney, and astringing essence — AI algorithm-optimized for syndrome differentiation, restoring pancreatic function through the Kidney Meridian of Foot-Shaoyin. Large-scale clinical trial subject recruitment and regulatory submission preparation are underway.
Research Highlights
- •Based on classical TCM formulas, multi-dimensionally optimized by modern AI algorithms
- •Pure herbal formula ingredients, balancing safety and efficacy
- •Ready for scalable production and market deployment
Learn More
Overview
Type I diabetes corresponds to the "Lower Wasting" severe form of Xiao-Ke in TCM. The 'Plain Questions' states: "This person must have frequently consumed sweet and rich foods; richness causes internal heat, sweetness causes middle fullness, thus qi overflows upward, transforming into Xiao-Ke." The root lies in kidney-yin deficiency with essence insecurity, involving the lungs and spleen. ZhengYiKang's Type I Diabetes therapeutic R&D achievement employs "nourishing yin, supplementing kidney; boosting qi, astringing essence; generating fluids, quenching thirst" as the treatment R&D approach, starting from the Kidney meridian while attending to Lung and Spleen.
R&D & Clinical Progress
This is a genuine ZhengYiKang TCM therapeutic R&D program targeting disease mechanisms through formula innovation and pharmacological research. **We are actively preparing large-scale clinical trial subject recruitment and submitting registration/approval materials to the relevant authorities.**
Until national drug or related registration approval is obtained, website content reflects R&D progress and clinical preparation only — not marketing of an approved drug. Patients must strictly follow physician guidance; never stop, reduce, or replace standard medical treatment on your own.
Herb Properties & Meridian Tropism
Mechanism of Action
Type I diabetes is most intimately connected with the Kidney (Foot-Shaoyin) and Spleen (Foot-Taiyin) meridians. "The kidney is the foundation of prenatal constitution" — when the Kidney meridian is deficient, essence is unsecured and leaks downward (glycosuria). "The spleen governs transportation and transformation" — when the Spleen meridian fails, food essence cannot be distributed and instead accumulates as damp-turbidity. The formula primarily uses herbs entering the Kidney and Spleen meridians with guiding herbs to deliver medicinal power directly: nourishing the Kidney meridian's yin to secure essence, strengthening spleen qi to aid transportation, and clearing lung-stomach heat to preserve fluids and quench thirst.
Therapeutic Research Directions
Suitable Scenarios
Usage
Twice daily after meals with warm water. Three 30-day courses recommended with blood glucose monitoring.
Preliminary Research Observations (not formal clinical trial data, for reference only)
Type I users on 3+ courses report smoother glucose curves; some reduced insulin under medical supervision with better energy and sleep.
Health Information Disclaimer
Content on ZhengYiKang (R&D achievements, Health Insights, AI apps) is for non-medical TCM wellness and general health information only. It does not replace in-person care from licensed professionals. Never stop or change medication based on this site alone.
FAQ
- What is ZhengYiKang's Type 1 diabetes therapeutic R&D achievement, and how does it relate to standard care?
- ZhengYiKang's Type 1 diabetes therapeutic R&D achievement is a TCM therapeutic R&D presentation based on the "Lower Wasting" theory — nourish yin, tonify kidney, supplement qi, generate fluids. It is for users interested in daily Type 1 diabetes therapeutic R&D and must be used alongside physician-directed treatment; never adjust insulin on your own.
- What is the TCM "Lower Wasting" theory and its relation to Type 1 therapeutic R&D?
- "Lower Wasting" is a classical TCM pattern within the "Wasting-Thirst" (diabetes) taxonomy, traditionally associated with kidney-yin deficiency and deficient fire. ZhengYiKang's formula offers a therapeutic research reference from nourish-yin and generate-fluids principles — not medical advice.
- How should the Type 1 therapeutic R&D achievement be used?
- Take twice daily, one sachet after meals with warm water, for 2–3 courses (30 days each), combined with blood sugar monitoring and medical guidance. Usage reference only; insulin management must remain under professional supervision.
- Can the Type 1 therapeutic R&D achievement replace insulin therapy?
- No. Type 1 diabetes requires exogenous insulin. ZhengYiKang's therapeutic R&D achievement cannot replace any insulin regimen. Always follow your physician's plan; never stop or adjust insulin on your own.
- How does ZhengYiKang's Type 1 formula relate to classical prescriptions and AI optimization?
- The formula inherits classical TCM prescription principles and uses ZhengYiKang's proprietary AI algorithms to optimize authentic herb compatibility — an R&D achievement presentation. AI is a research tool; the product is non-medical therapeutic R&D information, not a drug advertisement.
Comments
17 viewsAll Comments (0)
Loading comments…
Collaboration Models
We invite pharmaceutical companies, research institutions, and investors worldwide to join us in advancing TCM modernization and globalization
Technology Licensing
Joint R&D
Investment Partnership
Market Distribution
Why Partner With Us
Scientific Excellence
Ancient TCM formulas optimized by modern AI algorithms, with proprietary intellectual property
Market Potential
Trillion-dollar TCM health market with sustained demand growth
World-Class Team
Cross-disciplinary team of TCM experts and AI scientists
Full-Chain Support
End-to-end partnership support from R&D to commercialization
